Zhejiang Cancer Hospital: all 281 studies

Page 1 of 3. Open to participants first (116), then studies with results posted, then the rest; newest registration first within each.

• Anti-PD-1 in Combination With Systemic Chemotherapy With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant AscitesRecruitingNCT07855640
• An Exploratory Clinical Study Of Bempemab Combined With Anlotinib As First-Line Treatment For Elderly Patients With Locally Advanced Or Metastatic Non-Small-Cell Lung CancerNot yet recruitingNCT07849712Not applicable
• Platinum-Free Regimen in Nasopharyngeal CarcinomaNot yet recruitingNCT07794488Phase 2
• A Sequential Trial of Low-Dose Radiotherapy Followed by Concurrent Immunotherapy, Systemic Chemotherapy, and Intraperitoneal Perfusion in Gastric Cancer With Peritoneal CarcinomatosisNot yet recruitingNCT07784413Phase 2
• Immunotherapy Combined With Carbon Ion Radiotherapy for Locally Advanced Cervical CancerRecruitingNCT07702838Not applicable
• IBI343 Combined With Chemotherapy in Advanced Pancreatic CancerRecruitingNCT07692750Phase 1/2
• Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic CholangiocarcinomaNot yet recruitingNCT07691515Phase 3
• Research on AI Models for Predicting Breast Cancer Treatment Effectiveness to Guide Her-2 Targeted ADC TherapyNot yet recruitingNCT07689929
• Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical CancerNot yet recruitingNCT07673211
• Biodistribution, Dosimetry, and Safety of 68Ga-EV203 in Hematological MalignanciesRecruitingNCT07670949Not applicable
• Metronomic Oral Paclitaxel Monotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose-Finding and Expansion StudyRecruitingNCT07602907Phase 2
• A Prospective Observational Study of Senaparib in the Treatment of Epithelial Ovarian CancerNot yet recruitingNCT07586449
• Ultra-low-dose Radiation Therapy Followed by Orelabrutinib as First-line Treatment for Stage Ⅰ-Ⅱ MALT LymphomaRecruitingNCT07554898Phase 2
• A Phase II Clinical Study Evaluating the Effectiveness of Injectable NC527-X in Intraoperative Imaging for Patients With Solid TumorsRecruitingNCT07538648Phase 1
• CAR-T Combined With ASCT in the Treatment of Relapsed/Refractory Large B-cell Lymphoma With High-risk Factors.RecruitingNCT07538635Phase 2
• A Study on the Efficacy and Safety of Switching Between Two Targeted Strategies, HP+Chemotherapy and HPy+Chemotherapy, After Treatment Progression in HER-2 Positive Advanced or Metastatic Breast CancerRecruitingNCT07455188
• Safety and Efficacy of Umbilical Cord Blood Therapy for Cancer Therapy-Induced Thrombocytopenia (CTIT)RecruitingNCT07441720Phase 2
• Thiotepa in Combination With Pirtobrutinib (a BTK Inhibitor) and Sintilimab (a PD-1 Inhibitor) for Frail or Relapsed/Refractory Primary or Secondary Central Nervous System LymphomaRecruitingNCT07416890Phase 2
• Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain MetastasesNot yet recruitingNCT07343479Phase 2
• A Phase II Clinical Study Evaluating Entinostat With or Without Anlotinib + Fulvestrant for the Treatment of Hormone Receptor (HR) -Positive, Human Epidermal Growth Factor Receptor-2 (HER-2) -Negative Advanced Breast Cancer That Relapsed or Progressed After Endocrine TherapyRecruitingNCT07330544Phase 2
• Perioprative Study of IBI363 in Patients With MHC-II-Negative Locally Advanced Gastric CancerRecruitingNCT07325630Phase 2
• Efficacy and Safety of Distamab Vedotin Combined With Carboplatin for Advanced Ovarian Cancer in the First Line TreatmentRecruitingNCT07285941Phase 2
• Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard TherapyRecruitingNCT07284836Phase 2
• Real-Time Dynamic Imaging Study of Normal Pharyngolaryngeal Structures During Barium Swallow (GLAM-III)RecruitingNCT07264322
• LCMS-Based Metabolic Analysis Explores the Effect of American Ginseng on Urine and Plasma in Healthy IndividualsRecruitingNCT07252362Not applicable
• Firstline Sequential AG and mFOLFOX Combined With Serplulimab and Bevacizumab Versus AG Chemotherapy Alone in Advanced Pancreatic CancerRecruitingNCT07235930Phase 3
• An in Vivo CT Imaging Study of GMA-Tulip, I-gel, and LMA Supreme (GLAM-II)RecruitingNCT07196696Not applicable
• A Real-world Study on the Compliance of OFS-assisted Endocrine Therapy for Hormone Receptor-positive(HR+) Premenopausal Breast CancerNot yet recruitingNCT07180914
• Study on Safety and Efficacy of UCB-MNCs for Radiation-induced Lung InjuryNot yet recruitingNCT07177456Early Phase 1
• Study on Safety and Efficacy of UCB-MNCs for Chronic Radiation EnteritisNot yet recruitingNCT07175207Early Phase 1
• SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal CancerRecruitingNCT07162714Phase 2
• Irinotecan Liposomes in Total Neoadjuvant Therapy in Locally Advanced Rectal CancerNot yet recruitingNCT07074353Phase 3
• Clinical Evaluation of GRAPE Model for Gastric Cancer ScreeningRecruitingNCT07067983
• a Single Arm, Phase II Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of Iparomlimab and Tuvonralima b and Chemotherapy ± Bevacizumab Induction Therapy Followed by Concurrent Chemoradiotherapy in Patients With Advanced Cervical Cancer .Not yet recruitingNCT07035808Phase 2
• Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast CancerRecruitingNCT07014410Phase 2
• Zanubrutinib Plus GCVP (Obinutuzumab, Cyclophosphamide, Vindesine, Prednisolone) in Previously Untreated Follicular LymphomaNot yet recruitingNCT06918015Phase 2
• SH-LPS System in Preoperative Planning for Liver ResectionNot yet recruitingNCT06911086Phase 2/3
• Cerebrospinal Fluid Cytology-guided Intrathecal Chemo-holiday Therapy for EGFR-positive NSCLC Leptomeningeal MetastasesNot yet recruitingNCT06861218Phase 2
• Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCLRecruitingNCT06832267Not applicable
• Study of Pomalidomide Combination with Rituximab and Anti-PD-1 Antibody （PPR） in Third or Later Line Therapy of DLBCLRecruitingNCT06832228Not applicable
• To Investigate the Real-world Efficacy and Safety of Sacituzumab Govitecan for HER2 Negative Metastatic Breast Cancer Patients in China.RecruitingNCT06784921
• Sintilimab Combined With Bevacizumab and TP Chemotherapy in the Treatment of High Risk Locally-advanced NPCNot yet recruitingNCT06752382Phase 2
• Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular CarcinomaRecruitingNCT06741020Phase 1/2
• Pharmacokinetic Study of Tranexamic AcidRecruitingNCT06728670Not applicable
• Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients（PRECISION）RecruitingNCT06711432Not applicable
• RLC Followed by CR-CHOP in Elderly Patients with Newly-diagnosed DELRecruitingNCT06674096Phase 2
• Cadonilimab Combination Regimen as First-line Treatment for HER2-expressing GC/GEJ PatientsRecruitingNCT06650332Phase 1/2
• GEP Combined With Radiotherapy in Non-locally Treatable Recurrent NPCNot yet recruitingNCT06611826Phase 2
• CtDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: a Single-center, Randomized, Controlled StudyRecruitingNCT06609551Phase 3
• Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ PatiensRecruitingNCT06572319Phase 1/2
• Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung CancerRecruitingNCT06562920Phase 2
• Tislelizumab Combined with Nab-Paclitaxel for First-Line Treatment of Advanced Triple-Negative Breast Cancer with Bone Metastasis，an Exploratory, Single-Arm, Multicenter Phase II Clinical StudyRecruitingNCT06538896Phase 2
• Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CRIS-2 Trial）RecruitingNCT06509568Phase 2
• Combined Screening for Gastrointestinal TumorsRecruitingNCT06478030
• Phase II Study of Liposomal Irinotecan for Advanced Refractory Gastric CancerNot yet recruitingNCT06437678Phase 2
• Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell CarcinomaRecruitingNCT06422858Phase 2
• Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 GastrectomyNot yet recruitingNCT06419140Phase 2
• Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell CarcinomaRecruitingNCT06413342Phase 2
• Sequential AG and mFOLFOX Combined With Serplulimab Injection and Bevacizumab Injection in Untreated Advanced Pancreatic CancerRecruitingNCT06393166Phase 2
• Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal CarcinomaNot yet recruitingNCT06364826Phase 2
• Testing the Addition of Radiation Therapy to the Immune Therapy Treatment for ES-SCLCRecruitingNCT06350162Phase 2
• A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.RecruitingNCT06349044Not applicable
• Eribulin Combined With Sintilimab as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Breast Cancer:A Multicenter, Single-arm,Phase II Clinical TrialNot yet recruitingNCT06308939Phase 2
• Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal CancerRecruitingNCT06300489Phase 1
• A Phase II, Single-arm, Multicenter, Prospective Study of Cardunolizumab in Recurrent or Metastatic Vulvar and Vaginal CancerRecruitingNCT06292689Phase 2
• Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of ImmunotherapyRecruitingNCT06272214Phase 2
• Adebrelimab Combined With Fluzoparib in HRD-positive HR +/HER2- Advanced Breast CancerNot yet recruitingNCT06254066Phase 2
• The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac ToxicityRecruitingNCT06214195Phase 3
• Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRCNot yet recruitingNCT06195670Phase 1/2
• A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCCRecruitingNCT06190639Phase 2
• Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency AblationRecruitingNCT06178926Not applicable
• The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.Not yet recruitingNCT06140576Phase 1/2
• Surufatinib Plus Cadonilimab in Patients With Unresectable or Metastatic Bile Duct AdenocarcinomaRecruitingNCT06092645Phase 2
• A-RGEMOX in the Treatment of Early Relapsed/Refractory DLBCLRecruitingNCT06086197Phase 2
• Development of Novel Gastric Cancer Screening and Diagnosis Technologies Using Tongue Imaging and Study of Tongue Image Changes MechanismsRecruitingNCT06078930
• Prospective Observational Study to Predict the Response of Biliary Tract Tumors to ImmunotherapyRecruitingNCT06048289
• Sintilimab in Combination With S-1/Oxaliplatin With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant AscitesRecruitingNCT06046963Phase 2
• Radiotherapy Combined With ICIs as Treatment for LA-NSCLC After Failing Induction ImmunochemotherapyNot yet recruitingNCT06031597Phase 3
• 3D Printed Models for Liver SurgeryRecruitingNCT06006338Phase 1
• ZR2 Sequential Immunochemotherapy for Newly Treated MCLRecruitingNCT05992597Phase 2
• XPO-1 in Combination With RCHOP for DH/TH LymphomaRecruitingNCT05974085Phase 2
• Phase II Study of Fruquintinib Combined With Sintilimab and TACE for Inoperable Primary Hepatocellular CarcinomaRecruitingNCT05971199Phase 2
• Advanced Pancreatic CancerNot yet recruitingNCT05958849Phase 2
• Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal CancerNot yet recruitingNCT05928312Not applicable
• Lenvatinib Combined with Tislelizumab and TACE Applied As Neoadjuvant Regimen for the Patients of CNLC Stage IB and IIA Hepatocellular Carcinoma with High-risk Recurrence FactorsRecruitingNCT05920863Phase 2
• Combined Treatment of Treated Bile Duct CancerNot yet recruitingNCT05911425Phase 2
• Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular CarcinomaNot yet recruitingNCT05903456Phase 2
• A Study to Investigate the Efficacy and Safety of Tislelizumab Combined With Anlotinib as Maintenance Therapy for ES-SCLCRecruitingNCT05896059Phase 2
• Efficacy and Safety of Inetetamab Combined With Pyrotinib and Vinorelbine in ABCRecruitingNCT05856383
• A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell CarcinomaRecruitingNCT05705583
• Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric CancerNot yet recruitingNCT05669807Phase 2
• A Phase III Trial of Anus-preservation in Low Rectal Adenocarcinoma Based on MMR/MSI StatusRecruitingNCT05669092Phase 3
• SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPCRecruitingNCT05652192Phase 2
• PCI and Brain MRI Follow-up vs Brain MRI Follow-up Alone in Limited-stage SCLC PatientsRecruitingNCT05651802Not applicable
• A Single-Arm Phase II Exploratory Clinical Study of Pemigatinib in the Treatment of Advanced Gastrointestinal Cancer (Excluding Biliary Tract Cancer) Patients With FGFR Alterations Who Have Failed Standard TherapyRecruitingNCT05559775Phase 2
• GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of RecurrenceRecruitingNCT05557578Phase 2
• TRT for ES-SCLC After First Line Treatment With Immune Checkpoint InhibitorsRecruitingNCT05544149Phase 2
• Radiotherapy Combined With Endostatin and Capecitabine for NPCRecruitingNCT05514275Phase 2
• Watch and Wait for NeoAdjuvant Concurrent Radiochemotherapy Combined With Camrelizumab in Patients With Resectable ESCCRecruitingNCT05507411Phase 2
• Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world StudyNot yet recruitingNCT05480189

← Zhejiang Cancer Hospital overview and focus areas